Page last updated: 2024-08-23

mefloquine and Day Blindness

mefloquine has been researched along with Day Blindness in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikoma, Y; Kakita, A; Kitagawa, J; Mochizuki, K; Nakamichi, K; Ohe, N; Otsuki, M; Ozawa, K; Saijo, M; Shimohata, T; Takekoshi, A; Takeshima, A; Yoshikura, N1
Adabayeri, VM; Adjei, GO; Annobil, SH1
Bygbjerg, IC; Rønn, AM1

Other Studies

3 other study(ies) available for mefloquine and Day Blindness

ArticleYear
[A Patient with Progressive Multifocal Leukoencephalopathy Who Developed Bálint Syndrome Improved by Combination Therapy Using Mefloquine and Mirtazapine].
    Brain and nerve = Shinkei kenkyu no shinpo, 2019, Volume: 71, Issue:3

    Topics: Apraxias; Brain; DNA, Viral; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Mefloquine; Middle Aged; Mirtazapine; Vision Disorders

2019
Reversible binocular visual loss in temporal association with artesunate-amodiaquine treatment in a child on mefloquine chemoprophylaxis.
    Ghana medical journal, 2012, Volume: 46, Issue:3

    Topics: Amodiaquine; Anti-Inflammatory Agents; Antimalarials; Artemisinins; Chemoprevention; Child; Dexamethasone; Drug Combinations; Female; Humans; Malaria; Mefloquine; Time Factors; Vision Disorders; Visual Acuity

2012
[Long-lasting neuropsychiatric side-effects following mefloquine prophylaxis. A case after six weeks of initiating and lasting six months].
    Ugeskrift for laeger, 1999, Mar-08, Volume: 161, Issue:10

    Topics: Adult; Antimalarials; Anxiety Disorders; Brain Diseases; Female; Headache; Humans; Mefloquine; Mental Disorders; Neurologic Examination; Time Factors; Vision Disorders

1999